Business
Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System
(TheNewswire) First VMS+3.0 in UK and Seventh Hospital to Adopt the Lates...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n First VMS+3.0 in UK and Seventh\nHospital to Adopt the Latest VMS Technology\n \n \n \n \n Toronto, Ontario – TheNewswire –\nJanuary 4, 2021\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF) is pleased to announce that  the Company’s\nproprietary VMS+3.0 whole-heart analysis system has been installed at\nKings College Hospital (KCH) in London.  KCH is a major research and\nclinical centre in the UK.\n \n \n \n \n “This will help us evaluate patients with COVID-19,\nwho are known to have acute right-heart dilation and systolic\ndysfunction, and many develop chronic symptoms,” stated Dr. Mark\nMonaghan, Director of Non-Invasive Cardiology at KCH.  “It is\nimportant to compare the response of the heart to COVID-19 with other\nknown heart conditions, which can also be assessed with the\nVMS+3.0.”\n \n \n \n \n \n \n \n \n The NHS in the UK has announced an initiative to open\n40 new specialist clinics for COVID-19 patients with continuing\nsymptoms, “long COVID”, to build an expertise in assessing and\ntreating long-COVID patients\n(https://www.england.nhs.uk/2020/11/nhs-launches-40-long-covid-clinics-to-tackle-persistent-symptoms/).\n \n \n A study from King’s College London found\nthat older people, women and those with a greater number of different\nsymptoms in the first week of their illness were more likely to\ndevelop long COVID with one in 10 still unable to shake off the side\neffects eight weeks after infection.\n \n \n \n \n The Company estimates that 40,000 VMS+3.0 units would\nbe required based on standard-of-care guidelines to effectively\ndiagnose, monitor and manage the health of patients with congenital\nheart disease, pulmonary hypertension, suffering cardiotoxicity due to\nchemotherapy and COVID-19 infected patients.\n \n \n \n \n About Kings College Hospital London\n \n \n \n \n King's College Hospital\n \n \n (KCH) is\na\n \n \n \n \n major trauma\ncentre\n \n \n \n \n in\n \n \n \n \n Denmark\nHill\n \n \n \n \n ,\n \n \n \n \n Camberwell\n \n \n \n \n in\nthe\n \n \n \n...